FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Myfortic (mycophenolic acid) from Novartis. The approval updates the labeling to reflect changes from the supplement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection
• Solid Organ Transplant Rejection

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

SUPPL AP for MYFORTIC (MYCOPHENOLIC ACID)